BIOMAT Database Logo BIOMAT Database Logo

Effect of o,p'-DDD on plasma ACTH concentration in Cushing's disease. 1979

O D Bruno, and J C Hoschoian, and J A Andrada

UI MeSH Term Description Entries
D008939 Mitotane A derivative of the insecticide DICHLORODIPHENYLDICHLOROETHANE that specifically inhibits cells of the adrenal cortex and their production of hormones. It is used to treat adrenocortical tumors and causes CNS damage, but no bone marrow depression. o,p-DDD,ortho,para-DDD,Chloditan,Chlodithane,Khloditan,Lysodren,Mytotan,ortho,para DDD
D003480 Cushing Syndrome A condition caused by prolonged exposure to excess levels of cortisol (HYDROCORTISONE) or other GLUCOCORTICOIDS from endogenous or exogenous sources. It is characterized by upper body OBESITY; OSTEOPOROSIS; HYPERTENSION; DIABETES MELLITUS; HIRSUTISM; AMENORRHEA; and excess body fluid. Endogenous Cushing syndrome or spontaneous hypercortisolism is divided into two groups, those due to an excess of ADRENOCORTICOTROPIN and those that are ACTH-independent. Cushing's Syndrome,Hypercortisolism,Syndrome, Cushing,Syndrome, Cushing's
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006854 Hydrocortisone The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Cortef,Cortisol,Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-,11-Epicortisol,Cortifair,Cortril,Epicortisol,Hydrocortisone, (11 alpha)-Isomer,Hydrocortisone, (9 beta,10 alpha,11 alpha)-Isomer,11 Epicortisol
D000324 Adrenocorticotropic Hormone An anterior pituitary hormone that stimulates the ADRENAL CORTEX and its production of CORTICOSTEROIDS. ACTH is a 39-amino acid polypeptide of which the N-terminal 24-amino acid segment is identical in all species and contains the adrenocorticotrophic activity. Upon further tissue-specific processing, ACTH can yield ALPHA-MSH and corticotrophin-like intermediate lobe peptide (CLIP). ACTH,Adrenocorticotropin,Corticotropin,1-39 ACTH,ACTH (1-39),Adrenocorticotrophic Hormone,Corticotrophin,Corticotrophin (1-39),Corticotropin (1-39),Hormone, Adrenocorticotrophic,Hormone, Adrenocorticotropic
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013577 Syndrome A characteristic symptom complex. Symptom Cluster,Cluster, Symptom,Clusters, Symptom,Symptom Clusters,Syndromes

Related Publications

O D Bruno, and J C Hoschoian, and J A Andrada
Treatment of Cushing's disease with o,p'-DDD.
July 1979, The New England journal of medicine,
O D Bruno, and J C Hoschoian, and J A Andrada
o,p-DDD in the treatment of Cushing's disease.
May 1978, The Veterinary record,
O D Bruno, and J C Hoschoian, and J A Andrada
[Effect of chlodithane (o,p'-DDD) on transcortin binding ability in Itsenko-Cushing's disease].
January 1970, Fiziolohichnyi zhurnal,
O D Bruno, and J C Hoschoian, and J A Andrada
Effect of o,p'-DDD on cortisol secretory pattern in Cushing's syndrome.
August 1970, The Journal of clinical endocrinology and metabolism,
O D Bruno, and J C Hoschoian, and J A Andrada
[A case of Cushing's disease treated with o,p'-DDD].
October 1982, Horumon to rinsho. Clinical endocrinology,
O D Bruno, and J C Hoschoian, and J A Andrada
[Treatment of Cushing's disease with o, p'-DDD (author's transl)].
September 1981, Horumon to rinsho. Clinical endocrinology,
O D Bruno, and J C Hoschoian, and J A Andrada
Remission in Cushing's syndrome with o,p'-DDD.
March 1966, The Journal of clinical endocrinology and metabolism,
O D Bruno, and J C Hoschoian, and J A Andrada
Effect of o,p'-DDD on cortisol metabolism in Cushing's syndrome of various etiology.
October 1985, Endocrinologia japonica,
O D Bruno, and J C Hoschoian, and J A Andrada
[Effects of o,p'-DDD on pituitary-gonadal function in patients with Cushing's disease].
June 1988, Nihon Naibunpi Gakkai zasshi,
O D Bruno, and J C Hoschoian, and J A Andrada
The effect of o,p'-DDD therapy on plasma cholesterol in adrenal carcinoma.
November 1961, Proceedings of the staff meetings. Mayo Clinic,
Copied contents to your clipboard!